Contrary to CD8+T cells, NK cells respond to germline-markers of oncogenic transformation that are present on the surface of neoplastic plasma cells and not neoantigens presented by MHC-I, which is an advantageous characteristic in a low neoantigen presentation tumor, such as MM [94]. Here, CD8A is linked to Miyoshi myopathy.